Johnson & Johnson’s McNeil Consumer Healthcare unit is recalling 53,892 packages, or one lot, of the diarrhea treatment Imodium from distributors after discovering some of the packages could have a slight tear or hole.
The launch of “gluten-free” pizza that still should be avoided by people with full-blown celiac disease has prompted a physicians group to call for the standardization of the labeling of gluten-free foods.
Healthy food isn’t necessarily more expensive than junk food, according to a new government report.
Coffee drinkers are getting a bit more reassurance that their beverage of choice may not be bad for them, and might even be linked to living longer.
Cheaper genome sequencing means relatively soon you may get a chance to find your risks for different diseases. But do you really want to know?
Stanford University School of Medicine’s Michael Snyder has learned firsthand how gene sequencing can change a person’s daily life.
The FDA says the only oral multiple-sclerosis drug on the market shouldn’t be used in patients with a recent history of stroke or some heart problems.
Here’s what’s making health news this morning: Batteries Shown to Pose Risk for Kids (WSJ): ER visits by kids who’ve ingested batteries are rising, and of particular concern are little round “button” batteries found in many watches and other small devices, which can cause severe injury if they lodge in the esophagus.
Yesterday’s positive vote for Arena Pharmaceuticals’ lorcaserin raises the prospect that patients could soon have the first new drug therapy for weight loss in more than a decade. But as Dow Jones Newswires reports, we’re not quite there yet.
New Jersey Gov. Chris Christie vetoed legislation to create a statewide health-insurance exchange.